Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics

[1] Wells AW(2001)Erythroleukaemia in the north of England: a population based study J Clin Pathol 54 608-612

[2] Bown N(2010)Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification Blood 115 1985-1992

[3] Reid MM(2009)Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution Leukemia 23 2275-2280

[4] Hamilton PJ(2011)Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells Haematologica 96 1284-1292

[5] Jackson GH(2012)Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML PLoS One 7 e41485-4504

[6] Taylor PR(2003)6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group J Clin Oncol 21 4496-1848

[7] Hasserjian RP(2011)The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories Leukemia 25 1840-365

[8] Zuo Z(2010)Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials Blood 116 354-1282

[9] Garcia C(2013)Clonal diversity of recurrently mutated genes in myelodysplastic syndromes Leukemia 27 1275-2972

[10] Tang G(2012)A novel hierarchical prognostic model of AML solely based on molecular mutations Blood 120 2963-266

[1] Wells AW(2001)Erythroleukaemia in the north of England: a population based study J Clin Pathol 54 608-612

[2] Bown N(2010)Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification Blood 115 1985-1992

[3] Reid MM(2009)Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution Leukemia 23 2275-2280

[4] Hamilton PJ(2011)Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells Haematologica 96 1284-1292

[5] Jackson GH(2012)Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML PLoS One 7 e41485-4504

[6] Taylor PR(2003)6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group J Clin Oncol 21 4496-1848

[7] Hasserjian RP(2011)The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories Leukemia 25 1840-365

[8] Zuo Z(2010)Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials Blood 116 354-1282

[9] Garcia C(2013)Clonal diversity of recurrently mutated genes in myelodysplastic syndromes Leukemia 27 1275-2972

[10] Tang G(2012)A novel hierarchical prognostic model of AML solely based on molecular mutations Blood 120 2963-266